Selected research
Market Analysis & Forecast
Global AI Lung Image Analysis Market Analysis and Forecast 2026-2032
Market perspective
The global AI Lung Image Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AI Lung Image Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AI Lung Image Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AI Lung Image Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AI Lung Image Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AI Lung Image Analysis include GE HealthCare, Siemens Healthineers, Thirona, Philips Healthcare, Infervision, DeepWise, Huiying Medical, Aidoc and Lunit, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AI Lung Image Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AI Lung Image Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Lung Image Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI Lung Image Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Lung Image Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Lung Image Analysis revenue, projected growth trends, production technology, application and end-user industry.
AI Lung Image Analysis Segment by Company
GE HealthCare
Siemens Healthineers
Thirona
Philips Healthcare
Infervision
DeepWise
Huiying Medical
Aidoc
Lunit
Canon Medical Systems
Riverain Technologies
VoxelCloud
QUIBIM
Shukun Technology
AI Lung Image Analysis Segment by Type
2D Analysis
3D Analysis
AI Lung Image Analysis Segment by Application
Hospital
Clinic
Research Institution
Other
AI Lung Image Analysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Lung Image Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Lung Image Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Lung Image Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Lung Image Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Lung Image Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Lung Image Analysis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2D Analysis
- 3D Analysis
Applications
- Hospital
- Clinic
- Research Institution
- Other
Companies covered
- GE HealthCare
- Siemens Healthineers
- Thirona
- Philips Healthcare
- Infervision
- DeepWise
- Huiying Medical
- Aidoc
- Lunit
- Canon Medical Systems
- Riverain Technologies
- VoxelCloud
- QUIBIM
- Shukun Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AI Lung Image Analysis Market by Type
- 1.2.1 Global AI Lung Image Analysis Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 2D Analysis
- 1.2.3 3D Analysis
- 1.3 AI Lung Image Analysis Market by Application
- 1.3.1 Global AI Lung Image Analysis Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Research Institution
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Lung Image Analysis Market Dynamics
- 2.1 AI Lung Image Analysis Industry Trends
- 2.2 AI Lung Image Analysis Industry Drivers
- 2.3 AI Lung Image Analysis Industry Opportunities and Challenges
- 2.4 AI Lung Image Analysis Industry Restraints
3 Global Growth Perspective
- 3.1 Global AI Lung Image Analysis Market Perspective (2021-2032)
- 3.2 Global AI Lung Image Analysis Growth Trends by Region
- 3.2.1 Global AI Lung Image Analysis Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AI Lung Image Analysis Market Size by Region (2021-2026)
- 3.2.3 Global AI Lung Image Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AI Lung Image Analysis Revenue by Players
- 4.1.1 Global AI Lung Image Analysis Revenue by Players (2021-2026)
- 4.1.2 Global AI Lung Image Analysis Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AI Lung Image Analysis Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AI Lung Image Analysis Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AI Lung Image Analysis Key Players Headquarters & Area Served
- 4.4 Global AI Lung Image Analysis Players, Product Type & Application
- 4.5 Global AI Lung Image Analysis Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AI Lung Image Analysis Market CR5 and HHI
- 4.6.3 2025 AI Lung Image Analysis Tier 1, Tier 2, and Tier 3
5 AI Lung Image Analysis Market Size by Type
- 5.1 Global AI Lung Image Analysis Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AI Lung Image Analysis Revenue by Type (2021-2032)
- 5.3 Global AI Lung Image Analysis Revenue Market Share by Type (2021-2032)
6 AI Lung Image Analysis Market Size by Application
- 6.1 Global AI Lung Image Analysis Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AI Lung Image Analysis Revenue by Application (2021-2032)
- 6.3 Global AI Lung Image Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 GE HealthCare
- 7.1.1 GE HealthCare Company Information
- 7.1.2 GE HealthCare Business Overview
- 7.1.3 GE HealthCare AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.1.4 GE HealthCare AI Lung Image Analysis Product Portfolio
- 7.1.5 GE HealthCare Recent Developments
- 7.2 Siemens Healthineers
- 7.2.1 Siemens Healthineers Company Information
- 7.2.2 Siemens Healthineers Business Overview
- 7.2.3 Siemens Healthineers AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.2.4 Siemens Healthineers AI Lung Image Analysis Product Portfolio
- 7.2.5 Siemens Healthineers Recent Developments
- 7.3 Thirona
- 7.3.1 Thirona Company Information
- 7.3.2 Thirona Business Overview
- 7.3.3 Thirona AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.3.4 Thirona AI Lung Image Analysis Product Portfolio
- 7.3.5 Thirona Recent Developments
- 7.4 Philips Healthcare
- 7.4.1 Philips Healthcare Company Information
- 7.4.2 Philips Healthcare Business Overview
- 7.4.3 Philips Healthcare AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.4.4 Philips Healthcare AI Lung Image Analysis Product Portfolio
- 7.4.5 Philips Healthcare Recent Developments
- 7.5 Infervision
- 7.5.1 Infervision Company Information
- 7.5.2 Infervision Business Overview
- 7.5.3 Infervision AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.5.4 Infervision AI Lung Image Analysis Product Portfolio
- 7.5.5 Infervision Recent Developments
- 7.6 DeepWise
- 7.6.1 DeepWise Company Information
- 7.6.2 DeepWise Business Overview
- 7.6.3 DeepWise AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.6.4 DeepWise AI Lung Image Analysis Product Portfolio
- 7.6.5 DeepWise Recent Developments
- 7.7 Huiying Medical
- 7.7.1 Huiying Medical Company Information
- 7.7.2 Huiying Medical Business Overview
- 7.7.3 Huiying Medical AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.7.4 Huiying Medical AI Lung Image Analysis Product Portfolio
- 7.7.5 Huiying Medical Recent Developments
- 7.8 Aidoc
- 7.8.1 Aidoc Company Information
- 7.8.2 Aidoc Business Overview
- 7.8.3 Aidoc AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.8.4 Aidoc AI Lung Image Analysis Product Portfolio
- 7.8.5 Aidoc Recent Developments
- 7.9 Lunit
- 7.9.1 Lunit Company Information
- 7.9.2 Lunit Business Overview
- 7.9.3 Lunit AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.9.4 Lunit AI Lung Image Analysis Product Portfolio
- 7.9.5 Lunit Recent Developments
- 7.10 Canon Medical Systems
- 7.10.1 Canon Medical Systems Company Information
- 7.10.2 Canon Medical Systems Business Overview
- 7.10.3 Canon Medical Systems AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.10.4 Canon Medical Systems AI Lung Image Analysis Product Portfolio
- 7.10.5 Canon Medical Systems Recent Developments
- 7.11 Riverain Technologies
- 7.11.1 Riverain Technologies Company Information
- 7.11.2 Riverain Technologies Business Overview
- 7.11.3 Riverain Technologies AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.11.4 Riverain Technologies AI Lung Image Analysis Product Portfolio
- 7.11.5 Riverain Technologies Recent Developments
- 7.12 VoxelCloud
- 7.12.1 VoxelCloud Company Information
- 7.12.2 VoxelCloud Business Overview
- 7.12.3 VoxelCloud AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.12.4 VoxelCloud AI Lung Image Analysis Product Portfolio
- 7.12.5 VoxelCloud Recent Developments
- 7.13 QUIBIM
- 7.13.1 QUIBIM Company Information
- 7.13.2 QUIBIM Business Overview
- 7.13.3 QUIBIM AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.13.4 QUIBIM AI Lung Image Analysis Product Portfolio
- 7.13.5 QUIBIM Recent Developments
- 7.14 Shukun Technology
- 7.14.1 Shukun Technology Company Information
- 7.14.2 Shukun Technology Business Overview
- 7.14.3 Shukun Technology AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
- 7.14.4 Shukun Technology AI Lung Image Analysis Product Portfolio
- 7.14.5 Shukun Technology Recent Developments
8 North America
- 8.1 North America AI Lung Image Analysis Revenue (2021-2032)
- 8.2 North America AI Lung Image Analysis Revenue by Type (2021-2032)
- 8.2.1 North America AI Lung Image Analysis Revenue by Type (2021-2026)
- 8.2.2 North America AI Lung Image Analysis Revenue by Type (2027-2032)
- 8.3 North America AI Lung Image Analysis Revenue Share by Type (2021-2032)
- 8.4 North America AI Lung Image Analysis Revenue by Application (2021-2032)
- 8.4.1 North America AI Lung Image Analysis Revenue by Application (2021-2026)
- 8.4.2 North America AI Lung Image Analysis Revenue by Application (2027-2032)
- 8.5 North America AI Lung Image Analysis Revenue Share by Application (2021-2032)
- 8.6 North America AI Lung Image Analysis Revenue by Country
- 8.6.1 North America AI Lung Image Analysis Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AI Lung Image Analysis Revenue by Country (2021-2026)
- 8.6.3 North America AI Lung Image Analysis Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AI Lung Image Analysis Revenue (2021-2032)
- 9.2 Europe AI Lung Image Analysis Revenue by Type (2021-2032)
- 9.2.1 Europe AI Lung Image Analysis Revenue by Type (2021-2026)
- 9.2.2 Europe AI Lung Image Analysis Revenue by Type (2027-2032)
- 9.3 Europe AI Lung Image Analysis Revenue Share by Type (2021-2032)
- 9.4 Europe AI Lung Image Analysis Revenue by Application (2021-2032)
- 9.4.1 Europe AI Lung Image Analysis Revenue by Application (2021-2026)
- 9.4.2 Europe AI Lung Image Analysis Revenue by Application (2027-2032)
- 9.5 Europe AI Lung Image Analysis Revenue Share by Application (2021-2032)
- 9.6 Europe AI Lung Image Analysis Revenue by Country
- 9.6.1 Europe AI Lung Image Analysis Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AI Lung Image Analysis Revenue by Country (2021-2026)
- 9.6.3 Europe AI Lung Image Analysis Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AI Lung Image Analysis Revenue (2021-2032)
- 10.2 China AI Lung Image Analysis Revenue by Type (2021-2032)
- 10.2.1 China AI Lung Image Analysis Revenue by Type (2021-2026)
- 10.2.2 China AI Lung Image Analysis Revenue by Type (2027-2032)
- 10.3 China AI Lung Image Analysis Revenue Share by Type (2021-2032)
- 10.4 China AI Lung Image Analysis Revenue by Application (2021-2032)
- 10.4.1 China AI Lung Image Analysis Revenue by Application (2021-2026)
- 10.4.2 China AI Lung Image Analysis Revenue by Application (2027-2032)
- 10.5 China AI Lung Image Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AI Lung Image Analysis Revenue (2021-2032)
- 11.2 Asia AI Lung Image Analysis Revenue by Type (2021-2032)
- 11.2.1 Asia AI Lung Image Analysis Revenue by Type (2021-2026)
- 11.2.2 Asia AI Lung Image Analysis Revenue by Type (2027-2032)
- 11.3 Asia AI Lung Image Analysis Revenue Share by Type (2021-2032)
- 11.4 Asia AI Lung Image Analysis Revenue by Application (2021-2032)
- 11.4.1 Asia AI Lung Image Analysis Revenue by Application (2021-2026)
- 11.4.2 Asia AI Lung Image Analysis Revenue by Application (2027-2032)
- 11.5 Asia AI Lung Image Analysis Revenue Share by Application (2021-2032)
- 11.6 Asia AI Lung Image Analysis Revenue by Country
- 11.6.1 Asia AI Lung Image Analysis Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AI Lung Image Analysis Revenue by Country (2021-2026)
- 11.6.3 Asia AI Lung Image Analysis Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AI Lung Image Analysis Revenue (2021-2032)
- 12.2 SAMEA AI Lung Image Analysis Revenue by Type (2021-2032)
- 12.2.1 SAMEA AI Lung Image Analysis Revenue by Type (2021-2026)
- 12.2.2 SAMEA AI Lung Image Analysis Revenue by Type (2027-2032)
- 12.3 SAMEA AI Lung Image Analysis Revenue Share by Type (2021-2032)
- 12.4 SAMEA AI Lung Image Analysis Revenue by Application (2021-2032)
- 12.4.1 SAMEA AI Lung Image Analysis Revenue by Application (2021-2026)
- 12.4.2 SAMEA AI Lung Image Analysis Revenue by Application (2027-2032)
- 12.5 SAMEA AI Lung Image Analysis Revenue Share by Application (2021-2032)
- 12.6 SAMEA AI Lung Image Analysis Revenue by Country
- 12.6.1 SAMEA AI Lung Image Analysis Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AI Lung Image Analysis Revenue by Country (2021-2026)
- 12.6.3 SAMEA AI Lung Image Analysis Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst